Literature DB >> 32407817

Ketamine and rapid acting antidepressants: Are we ready to cure, rather than treat depression?

Chadi G Abdallah1, John H Krystal2.   

Abstract

Depression is a leading cause of disability, with often chronic course of illness and high treatment resistance in a large proportion of patients. In the current short perspective paper, we present evidence supporting the presence of synaptic-based chronic stress pathology (CSP) in depression and across a number of psychiatric disorders. We summarize the synaptic connectivity model of CSP, and briefly review related preclinical and clinical evidence, while providing appropriate references for more comprehensive reviews and alternative models. We then underscore some gaps in the literature and provide various tips for future directions. Published by Elsevier B.V.

Entities:  

Keywords:  Antidepressants; Depression; Ketamine; Rapamycin; Relapse prevention; Synaptic plasticity

Year:  2020        PMID: 32407817      PMCID: PMC7316409          DOI: 10.1016/j.bbr.2020.112628

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  64 in total

1.  Stress-induced grey matter loss determined by MRI is primarily due to loss of dendrites and their synapses.

Authors:  Mustafa S Kassem; Jim Lagopoulos; Tim Stait-Gardner; William S Price; Tariq W Chohan; Jonathon C Arnold; Sean N Hatton; Maxwell R Bennett
Journal:  Mol Neurobiol       Date:  2012-11-09       Impact factor: 5.590

2.  The Nucleus Accumbens and Ketamine Treatment in Major Depressive Disorder.

Authors:  Chadi G Abdallah; Andrea Jackowski; Ramiro Salas; Swapnil Gupta; João R Sato; Xiangling Mao; Jeremy D Coplan; Dikoma C Shungu; Sanjay J Mathew
Journal:  Neuropsychopharmacology       Date:  2017-03-08       Impact factor: 7.853

3.  Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism.

Authors:  Nolan R Williams; Boris D Heifets; Christine Blasey; Keith Sudheimer; Jaspreet Pannu; Heather Pankow; Jessica Hawkins; Justin Birnbaum; David M Lyons; Carolyn I Rodriguez; Alan F Schatzberg
Journal:  Am J Psychiatry       Date:  2018-08-29       Impact factor: 18.112

4.  Global prefrontal and fronto-amygdala dysconnectivity in bipolar I disorder with psychosis history.

Authors:  Alan Anticevic; Margaret S Brumbaugh; Anderson M Winkler; Lauren E Lombardo; Jennifer Barrett; Phillip R Corlett; Hedy Kober; June Gruber; Grega Repovs; Michael W Cole; John H Krystal; Godfrey D Pearlson; David C Glahn
Journal:  Biol Psychiatry       Date:  2012-09-11       Impact factor: 13.382

5.  Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States.

Authors:  Ronald C Kessler; Maria Petukhova; Nancy A Sampson; Alan M Zaslavsky; Hans-Ullrich Wittchen
Journal:  Int J Methods Psychiatr Res       Date:  2012-08-01       Impact factor: 4.035

6.  Sustained rescue of prefrontal circuit dysfunction by antidepressant-induced spine formation.

Authors:  R N Moda-Sava; M H Murdock; P K Parekh; R N Fetcho; B S Huang; T N Huynh; J Witztum; D C Shaver; D L Rosenthal; E J Alway; K Lopez; Y Meng; L Nellissen; L Grosenick; T A Milner; K Deisseroth; H Bito; H Kasai; C Liston
Journal:  Science       Date:  2019-04-12       Impact factor: 63.714

7.  Multimodal Investigation of Network Level Effects Using Intrinsic Functional Connectivity, Anatomical Covariance, and Structure-to-Function Correlations in Unmedicated Major Depressive Disorder.

Authors:  Dustin Scheinost; Sophie E Holmes; Nicole DellaGioia; Charlie Schleifer; David Matuskey; Chadi G Abdallah; Michelle Hampson; John H Krystal; Alan Anticevic; Irina Esterlis
Journal:  Neuropsychopharmacology       Date:  2017-09-25       Impact factor: 7.853

8.  Rapid Acting Antidepressants in Chronic Stress Models: Molecular and Cellular Mechanisms.

Authors:  Brendan D Hare; Sriparna Ghosal; Ronald S Duman
Journal:  Chronic Stress (Thousand Oaks)       Date:  2017-04-10

9.  Reduced Salience and Enhanced Central Executive Connectivity Following PTSD Treatment.

Authors:  Chadi G Abdallah; Christopher L Averill; Amy E Ramage; Lynnette A Averill; Evelyn Alkin; Samaneh Nemati; John H Krystal; John D Roache; Patricia Resick; Stacey Young-McCaughan; Alan L Peterson; Peter Fox
Journal:  Chronic Stress (Thousand Oaks)       Date:  2019-04-15

10.  Neurobiological and Systemic Effects of Chronic Stress.

Authors:  Bruce S McEwen
Journal:  Chronic Stress (Thousand Oaks)       Date:  2017-04-10
View more
  5 in total

Review 1.  Imaging synaptic density in depression.

Authors:  Sophie E Holmes; Chadi Abdallah; Irina Esterlis
Journal:  Neuropsychopharmacology       Date:  2022-06-29       Impact factor: 7.853

2.  Ketamine beyond anesthesia: Antidepressant effects and abuse potential.

Authors:  Keith A Trujillo; Sergio D Iñiguez
Journal:  Behav Brain Res       Date:  2020-07-31       Impact factor: 3.332

3.  Brain Networks Associated With COVID-19 Risk: Data From 3662 Participants.

Authors:  Chadi G Abdallah
Journal:  Chronic Stress (Thousand Oaks)       Date:  2021-12-21

Review 4.  The effects of social isolation stress and discrimination on mental health.

Authors:  Lasse Brandt; Shuyan Liu; Christine Heim; Andreas Heinz
Journal:  Transl Psychiatry       Date:  2022-09-21       Impact factor: 7.989

5.  Ketamine: A tale of two enantiomers.

Authors:  Luke A Jelen; Allan H Young; James M Stone
Journal:  J Psychopharmacol       Date:  2020-11-06       Impact factor: 4.153

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.